MSICS Pharma
PrivateLast Round
Seed
May 6, 2026
Total Funding Raised
$3.6M
Company Overview
MSICS Pharma is a biotechnology company developing medical-grade technology to grow and produce psilocybin for the treatment of mental health conditions such as PTSD, depression, and OCD.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MSICS Pharma Comps
Public and private peers based on sector, stage, and business model.
MSICS Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 6, 2026 |
MSICS Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FUSION | Seed |
| GlenRock Israel | Seed |
| SGL Acquisitions | Seed |
| L& Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
$3.6M round led by FUSION.
MSICS Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MSICS Pharma's valuation, stock price, and market status.
